Vertex Pharmaceuticals, Inc. (VRTX)
480.22
-2.83
(-0.59%)
USD |
NASDAQ |
Feb 26, 16:00
480.13
-0.09
(-0.02%)
After-Hours: 20:00
Vertex Pharmaceuticals Research and Development Expense (Annual) : 3.754B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Moderna, Inc. | 2.917B |
| Gilead Sciences, Inc. | 5.688B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |
| Pfizer Inc. | 10.44B |